Marita Kametas, MSN, FNP-BC, CMSRN, COCN
The study by D'Amico and colleagues underscores the importance of using biologic therapies early in the postoperative course to prevent endoscopic recurrence. Patients who require surgery should initiate biologic therapy as soon as they have completed postoperative healing. This will help prevent a recurrence of their Crohn's disease and limit the need for subsequent surgery in the future. Proactive monitoring for postoperative recurrence and prompt management of any inflammation identified is vital in improving long-term outcomes.
Meanwhile, Rosiou and colleagues highlight the importance of communication with the entire care team regarding the management of IBD flares. Proactive patient education about notifying the primary gastroenterology provider if they experience flare symptoms can help prevent inappropriate or excess steroid exposure. Steroid-sparing strategies for the induction and maintenance of IBD remission are pivotal in preventing side effects and long-term complications of steroid exposure. Steroids should be used as a short-term therapy while bridging to a safe and appropriate maintenance regimen.